NRSN:NASDAQ
Neurosense Therapeutics Ltd
$0.74
arrow_upward
+0.71%(+0.0052) 1D
$0.77
arrow_upward
+4.73% (+0.035)bedtimeAfter hours
Closed: Jun 12, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NRSN...
Open
$0.75
High
$0.77
Low
$0.71
Mkt. cap
25.95M
Avg. vol.
134.92K
Volume
181.90K
52-wk high
$2.52
52-wk low
$0.63
EPS
-$0.44
Beta
1.56
Shares outstanding
35.35M
No. of employees
17
Open
$0.75
High
$0.77
Low
$0.71
Mkt. cap
25.95M
Avg. vol.
134.92K
Volume
181.90K
52-wk high
$2.52
52-wk low
$0.63
EPS
-$0.44
Beta
1.56
Shares outstanding
35.35M
No. of employees
17
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to NRSN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NRSN in the last 3 months.
Highest
Current $0.74
$9.00 (+1,124.16%)
Average
$6.00 (+716.10%)
Lowest
$3.00 (+308.05%)
News stories
From sources across the web
TipRanks
·
1 day ago
NeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
Stock Titan
·
1 day ago
NeuroSense (Nasdaq: NRSN) secures South Korean patent protection for ALS therapy PrimeC
PR Newswire
·
1 day ago
NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS
About Neurosense Therapeutics Ltd
AI content may include mistakes. Learn more